What systemic examination should be performed in an antenatal care (ANC) patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Systemic Examination in Antenatal Care Patients

Every antenatal care patient should undergo a comprehensive systemic examination that includes blood pressure measurement, weight assessment, abdominal examination, and clinical assessment for edema and clonus, with specific attention to detecting signs of pre-eclampsia, cardiovascular compromise, and fetal well-being.

Essential Clinical Examinations

Cardiovascular Assessment

  • Blood pressure monitoring at every ANC visit is universally recommended and shows high compliance (>50%) across settings 1, 2, 3
  • Measure BP to screen for hypertension (≥140/90 mm Hg) and pre-eclampsia (≥160/110 mm Hg requires urgent treatment) 2
  • Clinical assessment for clonus in women with suspected or confirmed pre-eclampsia 2
  • For transgender men on testosterone therapy, assess for increased cardiovascular and atherosclerotic risk similar to natal male populations 4

Maternal Physical Examination

  • Weight measurement at each visit (compliance >50% in most settings) 3, 5
  • Edema assessment - particularly important for detecting pre-eclampsia, though compliance is often <50% 3, 5
  • Abdominal examination including:
    • Uterine height measurement (good predictor of severe growth retardation and perinatal death in rural settings) 6
    • Fetal heart sound assessment (reported in only 26.1% of studies, indicating a gap in practice) 3
    • Fetal position and movement 7

Symptom Assessment

At every assessment after 20 weeks, specifically inquire about 1:

  • Headache or visual disturbances (signs of pre-eclampsia)
  • Epigastric pain or vomiting (pre-eclampsia warning signs)
  • Reduced fetal movements
  • Vaginal bleeding

Laboratory Screening Components

The following tests should be performed based on risk assessment 8, 2, 9:

Universal screening:

  • Hemoglobin levels for anemia detection
  • Syphilis testing (55.1% compliance in studies) 3
  • HIV testing (47.8% compliance) 3
  • ABO and RhD blood typing
  • Proteinuria assessment (dipstick or 24-hour collection if pre-eclampsia suspected) 1, 2

Risk-based screening:

  • Gestational diabetes mellitus screening (40.6% compliance) 3
  • Urine testing for albumin/sugar (often limited by supply availability) 10, 5

Risk Stratification Framework

Early Pregnancy Risk Assessment (Before 20 Weeks)

Identify women requiring specialist referral if they have 1, 2:

Single high-risk factors:

  • Previous pre-eclampsia
  • Pre-existing hypertension (booking diastolic BP ≥90 mm Hg)
  • Pre-existing renal disease or proteinuria
  • Pre-existing diabetes
  • Multiple pregnancy
  • Antiphospholipid antibodies

Or any two of these factors:

  • First pregnancy
  • Age ≥40 years
  • BMI ≥35
  • Family history of pre-eclampsia
  • ≥10 years since last pregnancy
  • Booking diastolic BP ≥80 mm Hg

Monitoring Frequency After 20 Weeks

Level 1 (Low risk): Follow local protocols for healthy multiparous women 1

Level 2 (Moderate risk):

  • 24-32 weeks: Maximum 3-week intervals between assessments
  • 32 weeks to delivery: Maximum 2-week intervals 1

Fetal Assessment Components

Ultrasound Evaluation

  • Initial detailed ultrasound including fetal echocardiogram when indicated 8, 7
  • For pre-eclampsia: Assess fetal biometry, amniotic fluid, and umbilical artery Doppler at diagnosis, then every 2 weeks if normal 2
  • More frequent monitoring if fetal growth restriction present 2

Fetal Well-Being Tests (for high-risk pregnancies)

Initiate at 32-34 weeks, individualized based on risk 7:

  • Biophysical profile (fetal breathing, movement, tone, amniotic fluid)
  • Non-stress testing
  • Umbilical artery Doppler velocimetry (particularly for IUGR) 7

Critical Pitfalls to Avoid

  1. Don't rely solely on number of visits - content and quality of examinations matter more than visit frequency 11, 3

  2. Explain findings to patients - Blood pressure measurements and abdominal examinations are often performed without explanation, reducing patient engagement 10

  3. Don't delay initial contact - Many women present after 20 weeks; community-based messaging is needed to encourage earlier care 2, 5

  4. Ensure supplies are available - Urine testing and hemoglobin assessment often fail due to lack of supplies, not lack of protocol 10, 5

  5. Document danger signs counseling - Only 54% of women can identify obstetric danger signs, indicating inadequate counseling 10

Special Populations

Transgender Men and Non-Binary Patients

  • Refer for anesthetic assessment when booking for ANC 4
  • Assess cardiovascular risk related to testosterone therapy 4
  • Screen for higher rates of autism, anxiety, depression, and other psychiatric conditions 4
  • Use patient's chosen name, pronouns, and preferred anatomical terminology 4

High-Risk Conditions Requiring Enhanced Surveillance

Beyond routine examination, assess for 7:

  • Advanced maternal age
  • Obesity
  • Cyanotic heart disease
  • Thrombophilia
  • Thyroid disorders
  • Chronic renal disease
  • Connective tissue disease
  • Cholestasis
  • Hemoglobinopathies
  • History of unexplained stillbirth

References

Research

Quality assessment indicators in antenatal care worldwide: a systematic review.

International journal for quality in health care : journal of the International Society for Quality in Health Care, 2019

Guideline

acr appropriateness criteria assessment of fetal well-being.

Journal of the American College of Radiology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.